ロード中...
Docetaxel and Thalidomide as a Treatment Option for Androgen- Independent, Nonmetastatic Prostate Cancer
Prostate cancer usually presents with early-stage disease, yet a significant proportion of patients present or will progress to androgen-independent, nonmetastatic prostate cancer (AIPC). Chemotherapy has demonstrated statistically significant improvements in palliation of AIPC. Docetaxel in particu...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MedReviews, LLC
2003
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1502338/ https://ncbi.nlm.nih.gov/pubmed/16985953 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|